CoreWeave, Inc. Derivative Gain (Loss) Excluded from Effectiveness decreased by 38.3% to -$536.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 103.0%, from -$264.00M to -$536.00M. Over 2 years (FY 2023 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows a downward trend with a 562.6% CAGR.
abbv_derivative_gain_loss_excluded_from_effectiveness| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$7.00M | -$7.00M | -$7.00M | -$7.00M | -$40.66M | -$66.77M | -$104.38M | -$149.20M | -$264.00M | -$266.97M | -$310.56M | -$387.64M | -$536.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -480.8% | -64.2% | -56.3% | -42.9% | -76.9% | -1.1% | -16.3% | -24.8% | -38.3% |
| YoY Change | — | — | — | — | -480.8% | -853.8% | <-999% | <-999% | -549.4% | -299.9% | -197.5% | -159.8% | -103.0% |